Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting LIPA with ERX-41 Induces ER Stress and Inhibits Tumor Progression in Inflammatory Breast Cancer.

Biomolecules·2026

Same author

Estrogen receptor β target gene expression reveals novel repressive functions in aggressive breast cancer.

NPJ breast cancer·2026

Same author

Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis.

Cancers·2025

Same author

Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor.

Receptors (Basel, Switzerland)·2024

Same author

AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.

Circulation research·2024

Same author

ERβ as a mediator of estrogen signaling in inflammatory breast cancer.

Oncotarget·2023

Search research articles

Related Experiment Video

Updated: Feb 24, 2026

Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart

Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart

Published on: March 26, 2015

Quantification of Embryonic Myofiber Development by Immunofluorescence.

Harika Nagandla¹, M David Stewart^2,3

¹Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.

Methods in Molecular Biology (Clifton, N.J.)

|August 27, 2017

Summary

Mammalian muscle development involves two distinct phases: primary and secondary myogenesis. This study details methods for quantifying embryonic and fetal myofiber development in mice.

Keywords:

Development Immunofluorescence Muscle Myogenesis

More Related Videos

Quantitative Whole-mount Immunofluorescence Analysis of Cardiac Progenitor Populations in Mouse Embryos

Quantitative Whole-mount Immunofluorescence Analysis of Cardiac Progenitor Populations in Mouse Embryos

Published on: October 12, 2017

In Vitro Differentiation of Mature Myofibers for Live Imaging

In Vitro Differentiation of Mature Myofibers for Live Imaging

Published on: January 7, 2017

Related Experiment Videos

Last Updated: Feb 24, 2026

Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart

Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart

Published on: March 26, 2015

Quantitative Whole-mount Immunofluorescence Analysis of Cardiac Progenitor Populations in Mouse Embryos

Quantitative Whole-mount Immunofluorescence Analysis of Cardiac Progenitor Populations in Mouse Embryos

Published on: October 12, 2017

In Vitro Differentiation of Mature Myofibers for Live Imaging

In Vitro Differentiation of Mature Myofibers for Live Imaging

Published on: January 7, 2017

Area of Science:

Developmental Biology
Muscle Biology
Cellular Biology

Background:

Mammalian myogenesis, the process of muscle formation, occurs in two distinct, temporally separated phases: primary and secondary.
The primary phase produces embryonic myofibers shortly after somitogenesis, while the secondary phase generates fetal myofibers adjacent to embryonic ones.
Myogenic cells and resulting myofibers from these two waves exhibit unique characteristics.

Purpose of the Study:

To describe established methods for quantifying embryonic and fetal myofiber development.
To provide a reproducible protocol for analyzing distinct myofiber types in mouse embryos.

Main Methods:

Immunofluorescence staining of embryonic and fetal mouse tissues.
Microscopic analysis and quantification of myofiber characteristics.
Utilizing specific antibodies to differentiate between embryonic and fetal myofibers.

Main Results:

Established a quantitative method to assess myofiber development.
Demonstrated distinct morphological and developmental trajectories for embryonic and fetal myofibers.
Provided data supporting the unique nature of cells and fibers in each myogenic wave.

Conclusions:

The methods described allow for precise quantification of primary and secondary myogenesis.
This approach facilitates further research into the molecular mechanisms regulating distinct myofiber development.
Understanding these processes is crucial for regenerative medicine and treating muscle disorders.